Evaluation of Vaginal Self-sampling Diagnostic Performances to Identify Genital Infections

Asymptomatic Infections Clinical Trial

Official title: Evaluation of Vaginal Self-sampling Diagnostic Performances to Identify Genital Infections : A Large, Cross-sectional, Non-inferiority Trial

Status Completed

Clinical Trial Summary

Screening for genital infection (GI), sexually transmitted infection (STI) and asymptomatic carriage of group B streptococcus (GBS) in pregnant women is a common reason for medical appointments. Conventional testing is performed by using vaginal and/or cervical classic sampling (VCS). Vaginal self-sampling (VSS) has progressively emerged as an alternative to VCS for STI agent screening. The use of vaginal self-sampling (VSS) could facilitate follow-ups and potentially help in the prevention of gynaecological disorders.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Asymptomatic Infections
• Communicable Diseases
• Genital Infection
• Infection

• NCT number: NCT04039711
• Study type: Interventional
• Source: Hôpital Européen Marseille
• Status: Completed
• Phase: N/A
• Start date: October 20, 2015
• Completion date: April 6, 2018